Publications by Mark Madsen, Ph.D

 

Additional Publications

 

 

1.              Wilson CR, Madsen MT. Dichromatic absorptiometry of vertebral bone mineral content. Invest Radiol 1977; 12:180-184.

 

2.              Madsen MT. Vertebral and peripheral bone mineral content by photon absorptiometry. Invest Radiol 1977; 12:185-188.

 

3.              Alexander SS, Madsen MT, Kemmil RL. Xenon inhalation as an adjunct to computerized tomography of the brain: preliminary study. Invest Radiol 1977; 12:15-18.

 

4.              Madsen MT, Hichwa RD, Nickles RJ. An investigation of ll C methane, l3 N nitrous oxide and C acetylene as regional cerebral blood flow agents. Phys Med Biol 1981; 26:875-882.

 

5.              Berger B, Park C, Desai C, Madsen MT. Abnormal thallium-201 scan in patients with normal coronary artery: clinical correlation. Am J Cardiol 1983; 52:365-370.

 

6.              Thakur ML, Seifer CL, Madsen MT, et al. Neutrophil labelling: problems and pitfalls. Semin Nucl Med 1984; 14:107-117.

 

7.              Desai AG, Berger B, Madsen MT, et al. PYP scintigraphy for acute myocardial infarction: how useful is it? Clin Nucl Med 1985; 10:622-625.

 

8.              Madsen MT, Park CH. Enhancement of SPECT images by Fourier filtering the projection image set. J Nucl Med 1985; 26:395-402.

 

9.              Falls M, Park CH, Madsen MT. PerfusamineTM (IMP) brain SPECT atlas. Clin Nucl Med 1985; 10:443-449.

 

10.           Madsen MT, Nickles RJ. A precise method for correcting count rate losses in scintillation cameras. Med Phys 1986; 13:344-349.

 

11.           Intenzo C, Koh Y, Madsen MT, Park C. Septal infarction demonstrated on Tc-99m PYP SPECT. Clin Nucl Med 1986; II(2):82-83.

 

12.           Park CH, Madsen MT, McLellan T, Schwartzman RJ. Iofetamine HCI I-123 brain scanning in stroke: a comparison with transmission CT. Radiographics 1988 Mar; 8(2):305-26.

 

13.           Madsen MT, Park CH, Thakur ML. Dosimetry of I-131 ethiodol in the treatment of hepatoma. J Nucl Med 1988; 29:1038-1044.

 

14.           Yoo HS, Park CH, Suh JH, Lee JT, Kim DI, Kim BS, Madsen MT. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings. Cancer Chemother Pharmacol 1989; 23 Suppl:S54-8.

 

15.           Yoo HS, Park CH, Suh JH, Lee JT, Kim DI, Kim BS, Choi HJ, Madsen MT. Hepatocellular carcinoma; treatment with a radioiodinated fatty acid ester. Yonsei Med J 1988; 29(2):166-75.

 

16.           Chang W, Madsen MT, Wang L, Kirchner PT. A 3-D anthropomorphic brain phantom for ECT applications. Nucl Med Commun 1990; 11:11- 16.

 

17.           Madsen MT. A method for obtaining an approximate Wiener filter. Med Phys 1990; 17:126-130.

 

18.           Madsen MT, Argenyi EA, Preslar J and Kirchner PT. An improved method for quantifying left to right cardiac shunts. J Nucl Med 1991; 32:1808-1812.

 

19.           Madsen MT, Chang W, Hichwa RD. Spatial resolution and count density requirements in brain SPECT imaging. Phys Med Biol 1992; 37:1625-1636.

 

20.           Madsen MT. A simplified formulation of the gamma variate function. Phys Med Biol 1992; 37:1597-1600.

 

21.           Fahey F, Keyes JW, Harkness B, Madsen MT, et al. Sensitivity, resolution and image quality with a multi-head SPECT camera. J Nucl Med 1992; 33:1859-1863.

 

22.           Madsen MT, O'Leary DS, Andreasen NC, Kirchner PT. Dual isotope brain SPECT for monitoring cognitive activation: Physical considerations. Nucl Med Commun 1993;

23.           14:391-396.

 

24.           O'Leary DS, Madsen MT, Kirchner PT, Andreasen NC. Dual isotope brain SPECT for monitoring cognitive activation: Patient studies. Nucl Med Commun 1993; 14:397-404.

 

25.           Madsen MT, Kirchner PT, Edlin JP, Nathan MA, Kahn D. An emission based technique for obtaining attenuation correction data for myocardial SPECT studies. Nucl Med Commun1993; 14:689-695.

 

26.           Ben-Haim S, Kahn D, Weiner GJ, Madsen MT, Waxman AD, Williams CM, Clarke Pearson DL, Coleman ER. The safety and pharmacokinetics in adult subjects of an intravenously administered Tc-99m labeled 17 amino acid peptide (CYT 379). Nucl Med Biol 1994; 21:131-142.

 

27.           Kahn D, Weiner GJ, Ben-Haim S, Ponto LLB, Madsen MT, et al. Positron emitting tomographic measurements of bone marrow blood flow to the pelvis and lumbar vertebrae in young normal adults. Blood 1994; 83:958-963.

 

28.           Kahn D, Ben-Haim S, Bushnell D, Madsen MT, Kirchner P: Captopril-enhanced Tc99m-MAG3 renal scintigraphy in subjects with suspected renovascular hypertension. Nucl Med Commun 1994; 15:515-528.

 

29.           Kahn D, Follett KA, Bushnell DL, Nathan MA, Piper JG, Madsen MT, Kirchner PT: Diagnosis of recurrent brain tumor: value of 201 Tl-SPECT vs 18 Fluorodeoxyglucose PET. AJR 1994; 163:1459-1465.

 

30.           Bushnell DL, Madsen MT, Cremer S, Kahn D, Kirchner PT: Reliability and accuracy of dual radioisotope SPECT imaging for detection of focal hyperactivity simulating brain activation. Academic Radiol 1994; 2:26-32.

 

31.           Graham SL, Fahey FH, Madsen MT, van Aswegen A,Yester MV. Quantitation of SPECT performance. Med Phys 1995; 22:401-410.

 

32.           Seabold JE, Simonson TM,Weber PC , Thompson BH, Harris KG, Rezai K, Madsen MT, Hoffman HT. Cranial osteomylitis: diagnosis and follow-up with In-WBC/Tc-99m MDP bone SPECT, CT, and MR imaging. Radiology 1995; 196:779-788.

 

33.           Argenyi EE, Soffer EE, Madsen MT, Berbaum KS, Walkner WO. Scintigraphic evaluation of small bowel transit in healthy subjects: inter- and intrasubject variability. Am J Gastroenterol. 1995; 90(6):938-42.

 

34.           Madsen MT: An introduction to emission computed tomography. Radiographics 1995; 15:975-991.

 

35.           Madsen MT, Kirchner PT, Grover-McKay M, Aktay R, Seabold JS, Rezai K, Kelly G: Emission-based attenuation correction of myocardial perfusion studies. J Nucl Cardiol 1997; 4:477-486.

 

36.           Madsen MT: A method for quantifying SPECT uniformity. Med Phys 1997; 24:1696 1700.

 

37.           Madsen MT, Harkness BA. Proposition: Positron imaging with SPECT and dual-head scintillation cameras obviates the need for PET in oncologic imaging. Med Phys 1998; 25:2116-2118.

 

38.           Ponto LLB, Madsen MT, Hichwa RD, Mayr N, Yuh WTC, Magnotta VA, Watkins GLW, Ehrhardt JC. Assessment of blood flow in solid tumors using PET. Clinical PET Imaging 1999; 1:117-121.

 

39.           Madsen MT, Uppaluri R, Hoffman EA, McLennan G. Pulmonary CT image classification with evolutionary programming. Acad Radiol 1999; 6:736-741.

 

40.           Bushnell D, Nathan M, Madsen MT, Kahn D, Williams R. Quantitation of bone flare phenomenon in prostate cancer. Nucl Med Commun 1999; 20(10):875-81.

 

41.           Madsen MT. Pet attenuation correction using mean attenuation coefficients: a simulation study. IEEE Trans Nucl Sci, 1999; 46:2172-2176.

 

42.           Hichwa RD, Aykac M, Bilgen D, Madsen MT. Automatic self-correcting method for arterial blood sampling detectors used in PET imaging. IEEE Trans Nucl Sci, 1999; 46:2124-2127.

 

43.           Gies M, Kalender WA, Wolf H, Suess C, Madsen MT. Dose reduction in CT by anatomically adapted tube current modulation. I. Simulation studies. Med. Phys.1999; 26: 2235-2247.

 

44.           Bushnell DL, Madsen M, Kahn D, Nathan M, Williams RD. Enhanced uptake of 99Tcm-MDP in skeletal metastases from prostate cancer following initiation of hormone treatment: potential for increasing delivery of therapeutic agents. Nucl Med Commun 1999; 20(10):875-881.

 

45.           Mullan BF, Madsen MT, Messerle L, Kolesnichenko V, Kruger J. X-ray attenuation of high atomic number transition metal cluster compounds: A new paradigm for radiographic contrast agents. Acad Radiol 2000; 7(4):254-259.

 

46.           Madsen MT, Haller J, Commean PK, Vannier MW. A Device for Applying Static Loads on Transtibial Amputees During Spiral CT Examinations. J Rehabil Res Dev. 2000;37(4):383-387.

 

47.           Lee JR, Madsen MT, Bushnel D, Menda Y. A threshold method to improve tandardized uptake value reproducibility. Nucl Med Commun 2000; 21(7):685-690.

 

48.           Menda Y, Bushnell DL, Madsen MT, McLaughlin K, Kahn D, Kernstine KH. Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy. Nucl Med Commun 2001; 22(10):1077-1081.

 

49.           Kernstine KH, McLaughlin KA, Menda Y, Rossi NP, Kahn DJ, Bushnell DL, Graham MM, Brown CK, Madsen MT. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable non-small cell lung cancer? Annals Thorac Surg 2002; 73(2):394- 401, discussion 401-402.

 

50.           McGowan SE, Smith J, Holmes AJ, Smith LA, Businga TR, Madsen MT, Kopp UC, Kline JN. Vitamin A deficiency promotes bronchial hyperreactivity in rats by altering muscarinic M(2) receptor function. Am J Physiol Lung Cell Mol Physiol. 2002; 282(5):L1031-9.

 

51.           Juweid ME, Menda Y, O’Dorisio MS, Bushnell D, Blake M, Madsen MT, Johnson J, Graham MM. 111 IN-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma. Nucl Med Commun 2002; 23(10):983-989.

 

52.           Ponto LLB, Graham MM, Richmond JC, Ward CA, Clermont DA, Schmitt BA, Clark J, Conklin A, Weldon L, Watkins GL, Madsen MT, Hichwa RD. Contamination levels in blood samples drawn from the injection intravenous line. Molec Imag Biol 2003; 4(6):410- 414.

 

53.           Bushnell D, Madsen M, Kahn D. Enhancement of uptake of therapeutic radiopharmaceuticals in bone lesions. Eur J Nucl Med 2003; 30:331.

 

54.           Bushnell D, Menda Y, Madsen M, O’Dorisio T, Carlisle T, Zehr P, Ponto L, Karwal M, Parker S, Ponto J, Connolly M, Bouterfa H. Assessment of hepatic toxicity from treatment with 90 Y-SMT 487 (OctreoTher") in patients with diffuse somatostatin receptor positive liver metastases. Cancer Biother Radiopharm 2003; accepted for publication.